Endoscopic retrograde cholangiopancreatography

Area of Science:

• Gastroenterology and Endoscopy
• Minimally Invasive Procedures
• Biliary and Pancreatic Diseases

Background:

• Technological advancements in endoscopic retrograde cholangiopancreatography (ERCP) have been limited.
• Digestive Disease Week 2014 featured key studies on ERCP innovations.

Purpose of the Study:

• To review novel findings and emerging technologies in ERCP presented at DDW 2014.
• To highlight advancements in the diagnosis and treatment of biliary and pancreatic conditions via ERCP.

Main Methods:

• Review of studies presented at Digestive Disease Week 2014 focusing on ERCP.
• Discussion of techniques including nonsteroidal anti-inflammatory drugs, pancreatic duct stenting, and various stent applications.
• Exploration of advanced imaging and ablation techniques like cholangioscopy, pancreatoscopy, and confocal laser endomicroscopy.

Main Results:

• Nonsteroidal anti-inflammatory drugs and pancreatic duct stenting show potential for preventing post-ERCP pancreatitis.
• Optimized preoperative stent selection for periampullary tumors and use of metal stents for hilar strictures were discussed.
• Intraductal biliary tumor ablation using photodynamic therapy or radiofrequency ablation demonstrated promise.
• Single-operator cholangioscopy (SpyGlass) and direct peroral cholangioscopy indicate future development potential.
• Peroral pancreatoscopy and confocal laser endomicroscopy showed utility in evaluating biliary lesions.

Conclusions:

• Emerging ERCP technologies offer improved strategies for managing complications and treating complex biliary and pancreatic diseases.
• Advancements in endoscopic imaging and ablation techniques are expanding the diagnostic and therapeutic capabilities of ERCP.
• Continued research and development in ERCP are crucial for improving patient outcomes in gastroenterology.